Pioneering Experts

Who We Are

FibroBiologics is the leading biopharmaceutical company focused on developing and commercializing fibroblast cell-based therapies for patients suffering from chronic diseases.

Our proprietary fibroblast platform serves as the foundation for developing biologic cures and treatments for chronic disorders, including multiple sclerosis and other autoimmune disorders, wound care, skin disorders such as psoriasis, scleroderma, and eczema, degenerative disc disease, orthopedics, and cancer.

Currently, FibroBiologics holds 150+ U.S. and International issued/pending patents across a variety of clinical pathways, including multiple sclerosis, cartilage repair, degenerative disc, cancer, wound healing, and extension of life programs. 

FibroBiologics is leading the next generation of medical advancement in fibroblast cell-based therapies.

How We Came to Be ...

Due to the ethical, political, and religious concerns surrounding stem cell sourcing and use of fetal tissue, in addition to numerous issues and limitation with regards to manufacturing of stem cells for clinical use, researchers have been forced to develop alternative cell sourcing methods1, 2.

These current and potential future limitations have inspired scientists to look for other cell types as a possible alternative to stem cells3. Fibroblasts, one of the most abundant cells in the human body and present in all tissues and systems, have demonstrated many of the same characteristics as stem cells, but appear to be a better cell source due to their potency and ease of use4, 5.

Fibroblasts continue to show great promise and potential for the future

FibroBiologics was founded 2 years ago to deliver on that promise and harness the potential power of fibroblast cell-based therapies for patients, everywhere.

From research to medicine, FibroBiologics is fundamentally changing the treatment paradigm for chronic diseases by introducing biologic treatments and potential cures to the world.

“People who are crazy enough to change the world are the ones that do.”

–Steve Jobs

Leadership

Pete O’Heeron

Chairman/Founder/CEO

Mark Andersen, CFA, CPA

Chief Financial Officer

Hamid Khoja, Ph.D.

Chief Scientific Officer

Board of Directors

Pete O’Heeron

Chairman/Founder/CEO

Stacy Coen

Board of Directors

Robert E. Hoffman, CPA

Board of Directors

Matt Link

Board of Directors

Victoria Niklas, M.D.

Board of Directors

Richard C. Cilento, Jr.

Board of Directors

Scientific Advisory Board

Claudia Lucchinetti, M.D., Ph.D.

Scientific Advisory Board

S. Thomas Carmichael, M.D., Ph.D.

Scientific Advisory Board

Kate Rubins, Ph.D.

Scientific Advisory Board

Elizabeth Shpall, M.D.

Scientific Advisory Board

Neil Bhowmick, Ph.D.

Scientific Advisory Board

See What’s in the
FibroBiologics Pipeline